Claris Lifesciences Limited IPO subscription is receiving lukewarm of around 9% as of 25 November 2010. With price band of 278-293 per share, the Rs 300 crore issue of Ahmedabad-based sterile injection manufacturer ends with 26 November 2010.
The bio company is expecting to invest in fuel expansion with the raised money is also planning for repaying Rs 46 crore debt. 16.5 per cent stakeholders equity is offloaded with this initial public offering.
Claris is operating worldwide in 76 countries and has Read more...
tags: claris, claris ipo, claris lifesciences, claris lifesciences ipo, claris lifesciences ipo rating, claris lifesciences ipo subscription, claris lifesciences limited
No comments:
Post a Comment